passive immunization with Candida albicans antiproteinase as a prophylactic tool against the candidiasis
DOI:
https://doi.org/10.32007/jfacmedbagdad.4721651Keywords:
sometime, immunolglobulin, mtnunocomprmisedAbstract
Summary:
Background: life threating fungel disease is now a frequent substantial of the immunocomprimised host population . Candida infection has raised throughout the era of antibiotics & immunosuppressive chemotherapy.
Aim of study : to highlight the need for alternative immunprophlactic tool .Therefore the need to develop prophylactic or therapeutic immunolglobulin against candidacies Materials & Methods: 12.5 mg/ml. of Candida albicans proteinase enzyme was injected S/C into a group of five rabbits weighing 3 Kg. with complete Freund's adjuvant. Antisera was collected from the animals after 28 days . 0.2 ml of this antisera given l/V into two group of rabbits ; followed by 0.1 ml of the antiserum one of thses groups as control. the 21"1 group challenged with 2.8*10^7 cfu/ml of actively growing C. abicans for three days . the 3rd group received only 2,8*10A7 cfu/ml ofC. albicans for three days
Results: Test rabbits , which received both antisera and C. albicans , were completely protected when examined after six weeks . No symptoms of the diaease ; no pathological lesions could be seen in the organs ( Kidneys, liver and spleen ). Culture for C. albicans from these organs were all negative . In contrast to rabbits received challenged dose of Candida; they become sick , visceral organs showed profuse microabscesses . Candida was isolated from minced organs on culture .
Conclusion : the findings draws attention to an important fact that the passive immunizention can be applied to protect patients with leukemia and others immunocompromised individuals from serious infection of Candida . This discovery calles for application to open anew hope for these patients at least to diverse their suffer for sometime,
Downloads
Downloads
Published
Issue
Section
License
For all articles published in Journal of the Faculty of Medicine Baghdad, copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY NC 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper rights.